No Detail Found!

Sofosbuvir and Ribavirin in Chronic Hepatitis C Virus Patients with No Response or Relapse with Interferon Therapy

Author(s)
Shaimuna Fareeha Sajjad Pakistan Health Research Council, Research Centre, JPMC Karachi, Pakistan.
Waquaruddin Ahmed Pakistan Health Research Council, Research Centre, JPMC Karachi, Pakistan.
Syed Ejaz Alam Pakistan Health Research Council, Research Centre, JPMC Karachi, Pakistan.
Abstract
To determine the response rate to sofosbuvir and ribavirin in chronic Hepatitis C Virus (HCV) patients who did not respond or relapsed with interferon therapy. A case series study was performed at Jinnah Postgraduate Medical Centre (JPMC), Karachi from January 2017- January 2019. HCV RNA positive were initiated in eligible patients with sofosbuvir 400mg once daily and ribavirin 400mg orally according to body weight for six months. Rapid viral response (RVR) [normal/undetectable ALT and AST level or very low HCV RNA at 4-6 weeks]. HCVRNA, CP, ALT were checked after 3 months of stopping treatment to confirm sustained virologic response (SVR). Of 100 cases, 16 (16%) were non-responders while relapse was observed in 84 (84%) patients. Among the 13 cirrhosis patients, 11 (84.6%) achieved SVR. Females had a significantly higher response rate as compared to males (p value 0.034). The sustained virological response rate in interferon treated chronic hepatitis C patients retreated with sofosbuvir and ribavirin was found satisfactory.
Publication Details
Page(s) 139-143
DOI DOI not available
Published Journal: Journal of Dow University of Health Sciences, Volume: 14, Issue: 3, Year: 2020

Request the full text from PASTIC

Keywords
Sofosbuvir, Relapse, Chronic hepatitis C, Sustained virological response, non responder, ribavirin.
0

Citations

0

Downloads

32

Views